Síndrome de quilomicronemia familiar: experiencia pediátrica en Argentina
Author(s) -
Araujo Mb,
Etcheverry Pacheco,
Juan Garrahan,
Maria Alix Leite Araújo,
Gabriel Eiberma,
Natalia Etcheverr,
Gabriela Pacheco
Publication year - 2022
Publication title -
archivos argentinos de pediatria
Language(s) - Spanish
Resource type - Journals
SCImago Journal Rank - 0.236
H-Index - 19
eISSN - 1668-3501
pISSN - 0325-0075
DOI - 10.5546/aap.2022.e123
Subject(s) - medicine , asymptomatic , failure to thrive , acute pancreatitis , gynecology , pediatrics , surgery
Familial chylomicronemia syndrome (FCS) is a rare autosomal recessive disease, prevalence 1:200,000 - 1:1,000,000, and is characterized by fasting chylomicrons and very high triglycerides > 880 mg/dl. LPL is the most frequently affected gene, then APOC2, GPIHBP1, APOA5, LMF1, all of them compromising the function of lipoproteinlipase. FCS commonly presents in childhood with recurrent abdominal pain, eruptive xanthomas, failure to thrive, pancreatitis, and sometimes asymptomatic. The conventional treatment is dietetic fat restriction. The clinical outcome of 20 pediatric patients with FCS recruited from 4 hospitals in Argentina is reported.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom